scholarly journals The effectiveness of a monetary reimbursement model for weight reduction via a smartphone application: a preliminary retrospective study

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Jungeun Lee ◽  
Sujin Bae ◽  
Dohyung Park ◽  
Youngin Kim ◽  
Jisun Park
Keyword(s):  
Weight Loss ◽  
Retrospective Study ◽  
Food Intake ◽  
Weight Reduction ◽  
Financial Incentives ◽  
Retention Rate ◽  
Smartphone Application ◽  
Analysis Of Covariance ◽  
Related Information ◽  
Health Related

Abstract Weight loss for obese populations has been a challenging subject. There are numerous mobile applications to address weight loss, but the low retention rate is a barrier for the intervention. This is a retrospective study, aiming to investigate the effectiveness of financial incentives to achieve weight loss via a monetary reimbursement model on a smartphone application. Participants voluntarily purchased a 16-week mobile weight loss application program, and those who logged food intake three times a day received monetary reimbursement up to the full amount they initially paid. We analyzed health-related information and logged in-app activities from participants (N = 2,803) including age, sex, weight, food intake, and physical activity on their mobile healthcare application called Noom from January 2017 to April 2019. Analysis of covariance (ANCOVA) was used to compare differences between groups who succeeded and failed at food logging, controlling for baseline BMI. The ANCOVA found that participants who completed the food logging successfully for 16 weeks (N = 1,565) lost significantly more weight than those who failed food logging (N = 1,238, F = 56.0, p < 0.001). In addition, participants who were able to log their food intake successfully exercised more (F = 41.5, p < 0.001), read more in-app articles (F = 120.7, p < 0.001), and consumed more quantity of healthy foods (F = 12.8, p < 0.001). Monetary reimbursement is an effective tool for weight reduction by encouraging participants to monitor their health-related behaviors regularly.

scholarly journals Analysis of Answers to Queries among Anonymous Users with Gastroenterological Problems on an Internet Forum

2020 ◽  
Vol 17 (3) ◽  
pp. 1042 ◽  
Author(s):  
Mikołaj Kamiński ◽  
Michał Borger ◽  
Piotr Prymas ◽  
Agnieszka Muth ◽  
Adam Stachowski ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Weight Loss ◽  
Lower Quadrant ◽  
Diagnostic Interpretation ◽  
Related Information ◽  
Health Related ◽  
Life Threatening ◽  
Inflammatory Bowel ◽  
Internet Forums ◽  
Right Lower Quadrant

Internet forums are an attractive source of health-related information. We aimed to investigate threads in the gastroenterological section of a popular Polish medical forum for anonymous users. We characterised the following aspects in threads: the main problem of the original poster, declared ailments and rationale of the responses (rational, neutral, harmful or not related to the problem of the original poster). We analysed over 2717 forum threads initiated in the years 2010–2018. Users mostly asked for diagnosis of the problem [1814 (66.8%)], treatment [1056 (38.9%)] and diagnostic interpretation [308 (11.3%)]. The most commonly declared symptoms were abdominal pain [1046 (38.5%)], diarrhea [454 (16.7%)] and bloating [354 (13.0%)]. Alarm symptoms were mentioned in 309 (11.4%) threads. From the total 3550 responses, 1257 (35.4%) were assessed as rational, 693 (19.5%) as neutral, 157 (4.4%) as harmful and 1440 (40.6%) as not related to the user’s problem. The original poster’s declaration of blood in stool, dyspepsia, pain in the abdominal right lower quadrant, weight loss or inflammatory bowel disease was positively related to obtaining at least one potentially harmful response. Advice from anonymous users on Internet forums may be irrational and disregards alarm symptoms, which can delay the diagnosis of life-threatening diseases.

scholarly journals H-Rec2: A Novel Mobile-Social System for Automatic Health Recognition and Recommendation

2017 ◽  
Author(s):  
Huan Li ◽  
Kejie Lu ◽  
Qi Zhang
Keyword(s):  
Physical Activity ◽  
Health Status ◽  
Food Intake ◽  
Online Social Networks ◽  
Integrated Approach ◽  
Relevant Information ◽  
Overweight And Obesity ◽  
Personal Health Information ◽  
Related Information ◽  
Health Related

Over the past decades, overweight and obesity has become a global epidemic and the leading threat for death. To prevent the serious risk, an overweight or obese individual must apply a long-term weight-management strategy to control food intake and physical activities, which is however, not easy. Recently, with the advances of information technology, more and more people can use wearable devices and smartphones to obtain physical activity information, while they can also access various health-related information from Internet&nbsp;online social networks&nbsp;(OSNs). Nevertheless, there is a lack of an integrated approach that can combine these two methods in an efficient way. In this paper, we address this issue and propose a novel mobile-social framework for health recognition and recommendation, namely, H-Rec2. The main ideas of H-Rec2 include (1) to&nbsp;recognize&nbsp;the individual's health status using smartphone as a general platform, and (2) to recommend&nbsp;physical activity and food intake based on personal health information, life science principles, and health-related information obtained from OSNs. To demonstrate the potentials of the H-Rec2 framework, we develop a prototype that consists of four important components: (1) an activity recognition module that senses physical activity using accelerometer, (2) a health status modeling module that applies a novel algorithm to generate personalized health status index, (3) a restaurant information collection module that collects relevant information from OSN, and (4) a restaurant recommendation module that provides personalized and context-aware recommendation. To evaluate the prototype, we conduct both objective and subjective experiments, which confirm the performance and effectiveness of the proposed system.

scholarly journals Time-Restricted Eating Alters Food Intake Patterns, as Prospectively Documented by a Smartphone Application

Nutrients ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3396
Author(s):  
Samar Malaeb ◽  
Tasma Harindhanavudhi ◽  
Katrina Dietsche ◽  
Nick Esch ◽  
Emily N. C. Manoogian ◽  
...  
Keyword(s):  
Weight Loss ◽  
Food Intake ◽  
Dietary Patterns ◽  
Oral Intake ◽  
Smartphone Application ◽  
Eating Patterns ◽  
High Quality ◽  
Group 12 ◽  
Eating Occasions ◽  
Food Intake Patterns

Time-restricted eating (TRE) can facilitate weight loss, yet its effect on eating patterns remains unknown. Twenty adults with BMI ≥ 25 kg/m2 underwent a 12-week randomized trial, examining the effect of an 8-h, time-restricted eating intervention on dietary patterns. Oral intake was documented using a smartphone. Dietary patterns, assessed as frequency of eating occasions (EOs) and types of meals/snacks and beverages, were compared between baseline (T0), early-intervention (T1), and end-intervention (T2). At T1 and T2, both groups had less EOs compared to T0, with greater reduction seen in the TRE group (−28%) than the non-TRE group (−12%) at T2 (p = 0.01 vs. non-TRE). Comparing T1 to T0, the TRE group documented less incomplete meals (−32.5%: p = 0.02), high quality snacks (−23.6%: p = 0.03), and low quality snacks (−36.6%: p = 0.004). Comparing T2 to T0, the TRE group documented less incomplete meals (−33.9%: p = 0.03), high quality snacks (−28.1%: p < 0.001) and low quality snacks (−51.2%: p < 0.001). Caffeinated beverage intake was reduced in the TRE group at T1 (−20.2%) and T2 (−28.8%) vs. T0, but remained unaltered in the non-TRE group. By using a smartphone application to document dietary intake, TRE significantly reduced the number of EOs, snacks, and caffeinated beverages, relative to baseline and relative to the non-TRE.

Pharmacotherapy for Weight Reduction: Bupropion/Naltrexone Drugs for Obesity

2021 ◽  
Vol 15 (9) ◽  
pp. 2293-2295
Author(s):  
Sabeen Arjumand ◽  
Maira Bhatti ◽  
Zubaida Qayyum ◽  
Zarish Ghafoor ◽  
Fouzia Perveen
Keyword(s):  
Weight Loss ◽  
Food Intake ◽  
Combination Therapy ◽  
Weight Reduction ◽  
Eating Behaviors ◽  
Complex Interaction ◽  
Food Craving ◽  
Melanocortin System ◽  
Major Mechanism

Background: There is no valid and accurate documentation on the combination therapy of bupropion along with naltrexone. The experimentations on these actions of combination drugs have resulted in rare success. Methods: A complex interaction occurs in the central and peripheral nervous system for reducing weight loss. It is difficult to find out the major mechanism of action of these drugs on weight reduction. Naltrexone and bupropion is the experimental combination for reducing the weight. For obesity, the combination of naltrexone/bupropion therapy’s mechanism working is still unknown. Results: The attempts for weight loss rarely have a long-term effect. It is an outcome of more likely some complex interaction between various peripheral and Central Nervous systems, and an overwhelming lack of real obesity treatment may be explained. Based on the evidence that obesity involves a change in the hypothalamic melanocortin system in addition to a brain reward system, which causes food craving and mood swings, this investigational combination therapy of NB was developed. Naltrexone and bupropion work in an interesting way. Conclusion: It affects the parts of the brain that influences food craving, food intake, eating behaviors, and loss of body weight. We will have a review on the working of naltrexone, and bupropion separately, and Vivo, current in vitro, and clinical evidence will be provided, describing how NB affects food intake and food craving. Keywords: CNS, obesity, medicine, weight lose, NB, therapy.

scholarly journals The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Anna Thorsø Larsen ◽  
Sofie Gydesen ◽  
Nina Sonne ◽  
Morten Asser Karsdal ◽  
Kim Henriksen
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Gastric Emptying ◽  
Food Intake ◽  
Glucose Metabolism ◽  
Glucose Tolerance ◽  
Weight Reduction ◽  
Receptor Agonist ◽  
Calcitonin Receptor ◽  
Body Weight Reduction

Abstract Background Weight loss therapy is becoming more and more important, and two classes of molecules, namely amylin receptor and GLP-1 receptor agonists, have shown promise in this regard. Interestingly, these molecules have several overlapping pharmacological effects, such as suppression of gastric emptying, reduction of glucagon secretion and weight loss in common; however, they also have distinct effects on prandial insulin secretion. Hence, a combination of these two mechanisms is of significant interest. Methods In this study, we investigated the add-on potential of the dual amylin and calcitonin receptor agonist (DACRA) KBP-089 in combination with the GLP-1 receptor agonist liraglutide as obesity treatment in high-fat diet (HFD) fed rats. Results Increasing doses of KBP-089 and liraglutide alone and in combination were studied with respect to their effects on body weight, food intake and glucose metabolism during a 9-week intervention study conducted in HFD rats. Further, the gastric emptying rate during an oral glucose tolerance was assessed. Treatment with KBP-089 and liraglutide dose-dependently lowered body weight 15% (at 2.5 μg/kg/day) and 7% (at 400 μg/kg/day) in HFD rats, respectively, while the combination resulted in a 21% body weight reduction, which was mirrored by reduction in fat depot sizes. Gastric emptying and glucose metabolism were improved, primarily by KBP-089, although liraglutide led to a reduction in fasting plasma glucagon. Conclusion DACRAs complement GLP-1 on food intake, body weight, and glucose tolerance indicating the potential for an add-on therapy.

scholarly journals The Dual Amylin and Calcitonin Receptor Agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile 

2020 ◽  
Author(s):  
Anna Thorsø Larsen ◽  
Sofie Gydesen ◽  
Nina Sonne ◽  
Morten Asser Karsdal ◽  
Kim Henriksen
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Gastric Emptying ◽  
Food Intake ◽  
Glucose Metabolism ◽  
Glucose Tolerance ◽  
Weight Reduction ◽  
Receptor Agonist ◽  
Calcitonin Receptor ◽  
Body Weight Reduction

Abstract Background: Weight loss therapy is becoming more and more important, and two classes of molecules, namely amylin receptor and GLP-1 receptor agonists, have shown promise in this regard. Interestingly, these molecules have several overlapping pharmacological effects, such as suppression of gastric emptying, reduction of glucagon secretion and weight loss in common; however, they also have distinct effects on prandial insulin secretion. Hence, a combination of these two mechanisms is of significant interest. Methods: In this study, we investigated the add-on potential of the dual amylin and calcitonin receptor agonist (DACRA) KBP-089 in combination with the GLP-1 receptor agonist liraglutide as obesity treatment in high-fat diet (HFD) fed rats. Results: Increasing doses of KBP-089 and liraglutide alone and in combination were studied with respect to their effects on body weight, food intake and glucose metabolism during a 9-week intervention study conducted in HFD rats. Further, the gastric emptying rate during an oral glucose tolerance was assessed. Treatment with KBP-089 and liraglutide dose-dependently lowered body weight 15% (at 2.5 µg/kg/day) and 7% (at 400 µg/kg/day) in HFD rats, respectively, while the combination resulted in a 21% body weight reduction, which was mirrored by reduction in fat depot sizes. Gastric emptying and glucose metabolism were improved, primarily by KBP-089, although liraglutide led to a reduction in fasting plasma glucagon. Conclusion: DACRAs complement GLP-1 on food intake, body weight, and glucose tolerance indicating the potential for an add-on therapy.

scholarly journals The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

2021 ◽  
Author(s):  
Anna Thorsø Larsen ◽  
Sofie Gydesen ◽  
Nina Sonne ◽  
Morten Asser Karsdal ◽  
Kim Henriksen
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Gastric Emptying ◽  
Food Intake ◽  
Glucose Metabolism ◽  
Glucose Tolerance ◽  
Weight Reduction ◽  
Receptor Agonist ◽  
Calcitonin Receptor ◽  
Body Weight Reduction

Abstract Background: Weight loss therapy is becoming more and more important, and two classes of molecules, namely amylin receptor and GLP-1 receptor agonists, have shown promise in this regard. Interestingly, these molecules have several overlapping pharmacological effects, such as suppression of gastric emptying, reduction of glucagon secretion and weight loss in common; however, they also have distinct effects on prandial insulin secretion. Hence, a combination of these two mechanisms is of significant interest. Methods: In this study, we investigated the add-on potential of the dual amylin and calcitonin receptor agonist (DACRA) KBP-089 in combination with the GLP-1 receptor agonist liraglutide as obesity treatment in high-fat diet (HFD) fed rats. Results: Increasing doses of KBP-089 and liraglutide alone and in combination were studied with respect to their effects on body weight, food intake and glucose metabolism during a 9-week intervention study conducted in HFD rats. Further, the gastric emptying rate during an oral glucose tolerance was assessed. Treatment with KBP-089 and liraglutide dose-dependently lowered body weight 15% (at 2.5 µg/kg/day) and 7% (at 400 µg/kg/day) in HFD rats, respectively, while the combination resulted in a 21% body weight reduction, which was mirrored by reduction in fat depot sizes. Gastric emptying and glucose metabolism were improved, primarily by KBP-089, although liraglutide led to a reduction in fasting plasma glucagon. Conclusion: DACRAs complement GLP-1 on food intake, body weight, and glucose tolerance indicating the potential for an add-on therapy.

scholarly journals Who is Sharing Physical Activity, Diet and Weight Loss Information on Twitter? An Exploratory Thematic and Source Analysis of Tweets

2020 ◽  
Author(s):  
Niamh Mairead O'Kane ◽  
Michelle C McKinley ◽  
Aisling Gough ◽  
Jennifer Badham ◽  
Oluwaseun Ajao ◽  
...  
Keyword(s):  
Physical Activity ◽  
Weight Loss ◽  
Health Behaviours ◽  
Source Analysis ◽  
Related Information ◽  
Research Guidelines ◽  
Information Intermediaries ◽  
Health Related ◽  
Social Media Platforms ◽  
Twitter Users

Abstract BackgroundSocial media platforms such as Twitter are used increasingly to consume and share information, including health-related information. Previous research has analysed the obesity conversation on Twitter, but no work to date has explored content related to specific contributing health behaviours, such as physical activity, diet and weight loss. The aim of this study was to identify the content and source of physical activity, diet and weight loss information on Twitter, in order to identify common content and sources of these tweets.Methods Exploratory thematic and source analysis was conducted on tweets containing the words “physical activity”, “diet”, or “weight loss”, collected over a 7-day period in March 2017. Sources were coded as professional, non-professional, or information intermediaries (non-protected titles and potentially misleading terms, such as ‘personal trainer’). Tweets were coded as educational (news and research, guidelines and recommendations), or non-educational (promotional, conversational, behavioural, or directing to another platform).ResultsA 1% sample of tweets (n=1,433) was analysed. The majority of tweets (69.2%) were related to diet, and most tweets were non-educational in nature. Among non-educational tweets, promotion of products or services was the most commonly identified theme (33.4%). Educational tweets comprised just under a third of the sample, and most of these (96.8%; n=455) came from non-professionals or information intermediaries. Most of the educational tweets from a non-professional source (74.0%; n=296) were providing advice in the form of recommendations or guidelines. Only 1.3% of all tweets came from a professional source. ConclusionsOnly 3% of the educational information shared on Twitter regarding physical activity, diet and weight loss came from a professional source. This suggests that Twitter users are at high risk of receiving information from non-professional sources, which may include non-evidence-based information or potentially harmful misinformation.

scholarly journals The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

2020 ◽  
Author(s):  
Anna Thorsø Larsen ◽  
Sofie Gydesen ◽  
Nina Sonne ◽  
Morten Asser Karsdal ◽  
Kim Henriksen
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Gastric Emptying ◽  
Food Intake ◽  
Glucose Metabolism ◽  
Glucose Tolerance ◽  
Weight Reduction ◽  
Receptor Agonist ◽  
Calcitonin Receptor ◽  
Body Weight Reduction

Abstract Background Weight loss therapy is becoming more and more important, and two classes of molecules, namely amylin receptor and GLP-1 receptor agonists, have shown promise in this regard. Interestingly, these molecules have several overlapping pharmacological effects, such as suppression of gastric emptying, reduction of glucagon secretion and weight loss in common; however, they also have distinct effects on prandial insulin secretion. Hence, a combination of these two mechanisms is of significant interest. Methods In this study, we investigated the add-on potential of the dual amylin and calcitonin receptor agonist (DACRA) KBP-089 in combination with the GLP-1 receptor agonist liraglutide as obesity treatment in high-fat diet (HFD) fed rats. Results Increasing doses of KBP-089 and liraglutide alone and in combination were studied with respect to their effects on body weight, food intake and glucose metabolism during a 9-week intervention study conducted in HFD rats. Further, the gastric emptying rate during an oral glucose tolerance was assessed. Treatment with KBP-089 and liraglutide dose-dependently lowered body weight 15% (at 2.5 µg/kg/day) and 7% (at 400 µg/kg/day) in HFD rats, respectively, while the combination resulted in a 21% body weight reduction, which was mirrored by reduction in fat depot sizes. Gastric emptying and glucose metabolism were improved, primarily by KBP-089, although liraglutide led to a reduction in fasting plasma glucagon. Conclusion DACRAs complement GLP-1 on food intake, body weight, and glucose tolerance indicating the potential for an add-on therapy.

Using Popular Mobile Devices in Voice Therapy

2013 ◽  
Vol 23 (3) ◽  
pp. 82-87 ◽  
Author(s):  
Eva van Leer
Keyword(s):  
Exercise Behavior ◽  
Voice Therapy ◽  
Pure Oxygen ◽  
Mobile Platforms ◽  
Self Monitoring ◽  
Web Based ◽  
Motivational Messages ◽  
Related Information ◽  
Health Related ◽  
Tailored Approach

Mobile tools are increasingly available to help individuals monitor their progress toward health behavior goals. Commonly known commercial products for health and fitness self-monitoring include wearable devices such as the Fitbit© and Nike + Pedometer© that work independently or in conjunction with mobile platforms (e.g., smartphones, media players) as well as web-based interfaces. These tools track and graph exercise behavior, provide motivational messages, offer health-related information, and allow users to share their accomplishments via social media. Approximately 2 million software programs or “apps” have been designed for mobile platforms (Pure Oxygen Mobile, 2013), many of which are health-related. The development of mobile health devices and applications is advancing so quickly that the Food and Drug Administration issued a Guidance statement with the purpose of defining mobile medical applications and describing a tailored approach to their regulation.

Sign in / Sign up

Export Citation Format

Share Document